Learn about targeted therapies designed to attack certain breast cancer cells. Targeted therapies include trastuzumab (Herceptin), pertuzumab (Perjeta) and lapatinib (Tykerb).

Aug 10, 2021 · Targeted therapy for HER2-positive breast cancer In about 15% to 20% of breast cancers, the cancer cells make too much of a growth-promoting protein known as HER2. These …

Jan 15, 2025 · Anti-HER2 therapies (also called HER2 inhibitors or HER2-targeted therapies) are a class of medicines used to treat all stages of HER2-positive breast cancer, from early-stage to metastatic, …

Oct 22, 2024 · Treatment for early-stage HER2-positive breast cancer will likely include some combination of surgery, targeted therapy, chemotherapy, and possibly other therapies.

Jul 24, 2024 · What are HER2-targeted therapies? Traditional chemotherapy, radiation and surgery still play an important role in the treatment of HER2-positive cancers. These treatments often are used …

Apr 17, 2025 · One type of biologic targeted therapy currently being studied is monoclonal antibodies. These laboratory-manufactured proteins bind with certain cancers. Herceptin: Targeting HER2 …

Targeted therapies—a form of precision medicine—have represented some of the most important breakthroughs in breast cancer research. Today, oncologists have numerous targeted therapies to …

Feb 2, 2024 · Abnormal alterations in human epidermal growth factor receptor 2 (HER2, neu, and erbB2) are associated with the development of many tumors. It is currently a crucial treatment for …

4 days ago · Summary HER2-positive breast cancer, driven by an overproduction of HER2 proteins, has unique treatment options that improve outcomes. Treatments for early-stage HER2-positive cases …

3 days ago · Experts explore the evolving role of HER2 and TROP-2 targeted therapies in breast cancer treatment at SABCS 2025, highlighting ADC advancements. Antibody drug conjugates (ADCs) …